Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

Por Rini, Brian I., Quinn, David I., Baum, Michael, Wood, Laura S., Tarazi, Jamal, Rosbrook, Brad, Arruda, Lillian Shahied, Cisar, Laura, Roberts, W. Gregory, Kim, Sinil, Motzer, Robert J.
Publicado no Target Oncol (2014)